Nascent Biotech Inc (OTCMKTS:NBIO) Stock In Focus After Recent Development

September 14, 2022

It was a fairly good day in the markets for investors in Nascent Biotech Inc (OTCMKTS:NBIO) as the stock ended up with gains of as much as 4% for the day following an announcement from the company. The clinical stage biotech firm announced yesterday that it had been successful in concluding the fourth cohort in dosing patients for the Phase 1 trial for the evaluation of its product Pritumumab. Trading…

Read More >>

Nascent Biotech Inc (OTCMKTS:NBIO) Stock In Focus After Recent Development

May 5, 2022

Although it is true that the Nascent Biotech Inc (OTCMKTS:NBIO) stock was trading in a range on Wednesday, the company was actually in the news cycle and hence, it could be a good idea to perhaps take a look into it. Trading Data On Wednesday, NBIO stock ended flat at $0.14 with more than 528K shares traded, compared to its average volume of 217K shares. The stock moved within a…

Read More >>

5 OTC Stocks for Tuesday’s Watchlist: VKIN, CRYM, PRCX, SSOF, NBIO

Following were the notable penny stock buzzers in the previous session on high volume. Keep an eye on these stocks this week. If you are interested in nanocap stocks here is one you should look into Viking Energy Group (OTCMKTS:VKIN) may be one of the best ways to play skyrocketing energy prices.   VKIN  has proven oil and gas assets valued at over $96 million located in North America in Kansas,…

April 19, 2022
Read More >>